Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Binder

Showing results (281-290 of 293) with videos related to

Pageof 30
Sort By:
JMIR Research Protocols|July 4, 2023
Dynamic Modelling of Mental Resilience in Young Adults: Protocol for a Longitudinal Observational Study (DynaM-OBS)Carolin Wackerhagen, Ilya M Veer, Judith M C van Leeuwen, et al.
JMIR Research Protocols|March 20, 2019
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE StudyEva Clemens, Annelot Jm Meijer, Linda Broer, et al.
Journal of Hepatology|April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinomaMaryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.
The Pharmacogenomics Journal|November 1, 2019
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE StudyEva Clemens, Linda Broer, Thorsten Langer, et al.
Journal of Clinical Epidemiology|July 13, 2024
Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystemAngela M Kunzler, Claire Iannizzi, Jacob Burns, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2024
Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomesAlexander Rühle, Maria Weymann, Max Behrens, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2020
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort studyThorsten Langer, Eva Clemens, Linda Broer, et al.
Data in Brief|September 17, 2020
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE datasetThorsten Langer, Eva Clemens, Linda Broer, et al.
Journal of Medical Genetics|October 18, 2015
Genome-wide significant association with seven novel multiple sclerosis risk lociChristina M Lill, Felix Luessi, Antonio Alcina, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2018
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescentsJulianne Byrne, Desiree Grabow, Helen Campbell, et al.
Pageof 30

Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
JMIR Research Protocols|July 4, 2023
Dynamic Modelling of Mental Resilience in Young Adults: Protocol for a Longitudinal Observational Study (DynaM-OBS)Carolin Wackerhagen, Ilya M Veer, Judith M C van Leeuwen, et al.
JMIR Research Protocols|March 20, 2019
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE StudyEva Clemens, Annelot Jm Meijer, Linda Broer, et al.
Journal of Hepatology|April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinomaMaryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.
The Pharmacogenomics Journal|November 1, 2019
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE StudyEva Clemens, Linda Broer, Thorsten Langer, et al.
Journal of Clinical Epidemiology|July 13, 2024
Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystemAngela M Kunzler, Claire Iannizzi, Jacob Burns, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2024
Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomesAlexander Rühle, Maria Weymann, Max Behrens, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2020
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort studyThorsten Langer, Eva Clemens, Linda Broer, et al.
Data in Brief|September 17, 2020
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE datasetThorsten Langer, Eva Clemens, Linda Broer, et al.
Journal of Medical Genetics|October 18, 2015
Genome-wide significant association with seven novel multiple sclerosis risk lociChristina M Lill, Felix Luessi, Antonio Alcina, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2018
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescentsJulianne Byrne, Desiree Grabow, Helen Campbell, et al.
Pageof 30